VIELA BIO, INC. Operating Income
VIELA BIO, INC. reported Operating Income of -$153.88 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2021-03-01
- VIELA BIO, INC. operating income (loss) for the quarter ending 2020-12-31 was -$33.73M.
- VIELA BIO, INC. operating income (loss) for the quarter ending 2020-09-30 was -$38.22M.
- VIELA BIO, INC. operating income (loss) for the quarter ending 2020-06-30 was -$39.82M.
- VIELA BIO, INC. operating income (loss) for the quarter ending 2020-03-31 was -$42.11M.
- VIELA BIO, INC. operating income (loss) for fiscal 2020 was -$153.88M.
- VIELA BIO, INC. operating income (loss) for fiscal 2019 was -$89.69M.
- VIELA BIO, INC. operating income (loss) for fiscal 2018 was -$192.31M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$33.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$71.95M derived: sum of 2 quarters · filed 2021-03-01 | -$111.77M derived: sum of 3 quarters · filed 2021-03-01 | -$153.88M 10-K · filed 2021-03-01 |
| 2020-09-30 | -$38.22M 10-Q · filed 2020-11-10 | -$78.04M derived: sum of 2 quarters · filed 2020-11-10 | -$120.15M 10-Q · filed 2020-11-10 | -$133.15M derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-06-30 | -$39.82M 10-Q · filed 2020-08-12 | -$81.93M 10-Q · filed 2020-08-12 | -$94.93M derived: sum of 3 quarters · filed 2020-08-12 | -$143.86M derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-03-31 | -$42.11M 10-Q · filed 2020-05-13 | -$55.11M derived: sum of 2 quarters · filed 2020-05-13 | -$104.04M derived: sum of 3 quarters · filed 2020-11-10 | -$110.15M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-12-31 | -$13.00M 10-K · filed 2020-03-25 | -$61.93M derived: sum of 2 quarters · filed 2020-11-10 | -$68.04M derived: sum of 3 quarters · filed 2020-11-10 | -$89.69M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$48.93M 10-Q · filed 2020-11-10 | -$55.04M derived: sum of 2 quarters · filed 2020-11-10 | -$76.69M 10-Q · filed 2020-11-10 | -$92.38M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$6.11M 10-Q · filed 2020-08-12 | -$27.76M 10-Q · filed 2020-08-12 | -$43.45M derived: sum of 3 quarters · filed 2020-08-12 | -$59.78M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$21.65M 10-Q · filed 2020-05-13 | -$37.34M derived: sum of 2 quarters · filed 2020-05-13 | -$53.67M derived: sum of 3 quarters · filed 2020-05-13 | -$66.57M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$15.69M 10-K · filed 2020-03-25 | -$32.02M derived: sum of 2 quarters · filed 2020-03-25 | -$44.92M derived: sum of 3 quarters · filed 2020-03-25 | -$192.31M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$16.33M 10-K · filed 2020-03-25 | -$29.23M derived: sum of 2 quarters · filed 2020-03-25 | -$176.62M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$12.90M 10-K · filed 2020-03-25 | -$160.29M derived: sum of 2 quarters · filed 2020-03-25 | ||
| 2018-03-31 | -$147.39M 10-K · filed 2020-03-25 |